Renaissance Technologies
BLUE

Renaissance Technologies’s bluebird bio BLUE Stock Holding History

Renaissance Technologies’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-52,909
Closed -$550K – 3579
2024
Q3 		$550K Buy
52,909
+13,334
+34% +$222K ﹤0.01% 2745
2024
Q2 		$779K Sell
39,575
-69,810
-64% -$1.4M ﹤0.01% 2466
2024
Q1 		$2.8M Sell
109,385
-22,550
-17% -$578K ﹤0.01% 1802
2023
Q4 		$3.64M Buy
131,935
+108,190
+456% +$6.6M 0.01% 1554
2023
Q3 		$1.44M Sell
23,745
-3,765
-14% -$264K ﹤0.01% 2058
2023
Q2 		$1.81M Buy
+27,510
New +$2.01M ﹤0.01% 2064
2022
Q4 		– Sell
-37,856
Closed -$4.79M – 4123
2022
Q3 		$4.79M Sell
37,856
-102,644
-73% -$11.6M 0.01% 1473
2022
Q2 		$11.6M Buy
140,500
+93,500
+199% +$7.25M 0.01% 1020
2022
Q1 		$4.56M Buy
+47,000
New +$6.2M 0.01% 1666
2021
Q1 		– Sell
-46,606
Closed -$26.1M – 3319
2020
Q4 		$26.1M Buy
46,606
+30,054
+182% +$19M 0.03% 624
2020
Q3 		$11.6M Buy
+16,552
New +$12.9M 0.01% 1041
2018
Q2 		– Sell
-7,705
Closed -$17M – 3265
2018
Q1 		$17M Buy
+7,705
New +$19.6M 0.02% 1026
2017
Q4 		– Sell
-6,083
Closed -$10.8M – 3334
2017
Q3 		$10.8M Buy
+6,083
New +$8.5M 0.01% 1278
2016
Q3 		– Sell
-6,369
Closed -$3.57M – 3330
2016
Q2 		$3.57M Buy
6,369
+3,389
+114% +$1.92M 0.01% 1832
2016
Q1 		$1.64M Buy
+2,980
New +$1.83M ﹤0.01% 2337
2015
Q3 		– Sell
-3,520
Closed -$7.68M – 3164
2015
Q2 		$7.68M Sell
3,520
-1,305
-27% -$2.66M 0.02% 1141
2015
Q1 		$7.55M Sell
4,825
-5,280
-52% -$6.97M 0.02% 1116
2014
Q4 		$12M Buy
10,105
+5,867
+138% +$3.92M 0.03% 776
2014
Q3 		$1.97M Buy
+4,238
New +$1.96M 0.01% 1683

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Renaissance Technologies's BLUE Position: Q4 2024 in Review

Renaissance Technologies sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 52,909 shares — an estimated $550K sold.

Renaissance Technologies first reported a position in BLUE in Q3 2014 and held it in 19 quarters. The position peaked at $26.1M in Q4 2020. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Renaissance Technologies reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 52,909 bluebird bio shares in Q4 2024, an estimated $550K.
  • Renaissance Technologies first reported a position in bluebird bio in Q3 2014 and held it in 19 quarters.
  • Renaissance Technologies's bluebird bio position peaked at $26.1M in Q4 2020.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.